RADIANT
Showing 26 - 50 of 665
Osteoarthritis, Knee, Pain Trial in United States (CGS-200-1, CGS-200-5, CGS-200 Vehicle)
Osteoarthritis, Knee, Osteoarthritis, Hip Trial in United States (Fasinumab, Diclofenac, Celecoxib)
Completed
- Osteoarthritis, Knee
- Osteoarthritis, Hip
- Fasinumab
- +3 more
-
Anniston, Alabama
- +70 more
Mar 9, 2022
Actinic Keratosis Trial in United States (Imiquimod Cream, 3.75%, Zyclara®, Vehicle of Test Product)
Completed
- Actinic Keratosis
- Imiquimod Cream, 3.75%
- +2 more
-
Tucson, Arizona
- +22 more
Nov 6, 2020
Osteoarthritis, OA Knee Pain, Arthritis Trial in United States (RN624 (PF-04383119))
Completed
- Osteoarthritis
- +2 more
- RN624 (PF-04383119)
-
Birmingham, Alabama
- +35 more
Jan 11, 2021
Rare and Atypical Diabetes Network
Recruiting
- Diabetes Mellitus
- +6 more
-
Aurora, Colorado
- +13 more
Sep 14, 2022
Binge Eating Disorder Trial in Worldwide (Lisdexamfetamine dimesylate, Placebo)
Completed
- Binge Eating Disorder
- Lisdexamfetamine dimesylate
- Placebo
-
Fort Myers, Florida
- +52 more
Jun 9, 2021
Radiation Exposure Trial (vascular access for coronary procedures)
Not yet recruiting
- Radiation Exposure
- vascular access for coronary procedures
- (no location specified)
Jun 1, 2020
Non-Alcoholic Steatohepatitis Trial in Worldwide (EDP-305 Dose 1, EDP-305 Dose 2, Placebo)
Completed
- Non-Alcoholic Steatohepatitis
- EDP-305 Dose 1
- +2 more
-
Chandler, Arizona
- +81 more
Aug 19, 2021
Healthy Trial in Chandler (Thermal Adhesion Patch)
Terminated
- Healthy
- Thermal Adhesion Patch
-
Chandler, ArizonaRadiant Research, Inc.
Aug 10, 2020
A/Vietnam/H5N1 Influenza Virus Trial in United States (7.5 mcg H5N1 (stored as monobulk), 15 mcg H5N1 (stored as monobulk), 90
Completed
- A/Vietnam/H5N1 Influenza Virus
- 7.5 mcg H5N1 (stored as monobulk)
- +5 more
-
Atlanta, Georgia
- +5 more
Aug 14, 2020
Migraine, Acute Treatment of Migraine Trial in United States (Rimegepant, Placebo, Sumatriptan)
Completed
- Migraine
- Acute Treatment of Migraine
- Rimegepant
- +2 more
-
Scottsdale, Arizona
- +40 more
Dec 15, 2022
Plaque Psoriasis Trial in United States (AGN-242428, Placebo)
Dysmenorrhea Trial in United States (Naproxen Sodium, (Aleve, BAY117031), Acetaminophen (Tylenol Extra Strength))
Completed
- Dysmenorrhea
- Naproxen Sodium, (Aleve, BAY117031)
- Acetaminophen (Tylenol Extra Strength)
-
Chandler, Arizona
- +7 more
Oct 25, 2019
Acne Vulgaris Trial in Australia, Canada, United States (Olumacostat Glasaretil Gel, 5.0%, Olumacostat Glasaretil Gel, Vehicle)
Completed
- Acne Vulgaris
- Olumacostat Glasaretil Gel, 5.0%
- Olumacostat Glasaretil Gel, Vehicle
-
Guntersville, Alabama
- +45 more
Jul 16, 2021
Glycemic Control Trial in United States (Usual Diet Group, Group 1 Nutritional Shake, Group 2 Nutritional Shake)
Completed
- Glycemic Control
- Usual Diet Group
- +2 more
-
Scottsdale, Arizona
- +7 more
Jan 13, 2020
Plaque Psoriasis, Skin Diseases Trial in Canada, United States (JTE-051, Placebo)
Terminated
- Plaque Psoriasis
- Skin Diseases
- JTE-051
- Placebo
-
Fountain Valley, California
- +15 more
Jul 15, 2021
Atopic Dermatitis Trial in Germany, United States (Pimecrolimus, Topical corticosteroids)
Completed
- Atopic Dermatitis
- Pimecrolimus
- Topical corticosteroids
-
Phoenix, Arizona
- +30 more
Feb 4, 2022
Acute Migraine Trial in United States (Lasmiditan 100 mg, Lasmiditan 200 mg, Placebo (matches lasmiditan doses))
Completed
- Acute Migraine
- Lasmiditan 100 mg
- +2 more
-
Birmingham, Alabama
- +91 more
Dec 2, 2019